VERTECHY, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 536
EU - Europa 135
AS - Asia 59
AF - Africa 5
Totale 735
Nazione #
US - Stati Uniti d'America 533
IT - Italia 42
SE - Svezia 34
IN - India 23
DE - Germania 20
SG - Singapore 20
FI - Finlandia 19
CN - Cina 16
BG - Bulgaria 6
TG - Togo 5
CA - Canada 3
GB - Regno Unito 3
UA - Ucraina 3
BE - Belgio 2
IE - Irlanda 2
RO - Romania 2
ES - Italia 1
MK - Macedonia 1
Totale 735
Città #
Fairfield 114
Ashburn 54
Ann Arbor 43
Seattle 36
Woodbridge 35
Cambridge 34
Houston 34
Wilmington 30
Rome 23
Chandler 18
Beijing 12
Dearborn 12
Bremen 11
Helsinki 11
Princeton 10
Plano 9
Singapore 9
Boston 6
Sofia 6
Lawrence 5
Lomé 5
San Diego 5
San Paolo di Civitate 5
Millbury 4
Norwalk 4
Andover 3
Bühl 3
Pomezia 3
Brussels 2
Dublin 2
Fremont 2
Hefei 2
New York 2
Toronto 2
Anaheim 1
Chicago 1
Falls Church 1
Fort Worth 1
Grafing 1
Hyderabad 1
Mannheim 1
Milan 1
Nanjing 1
Ottawa 1
Santa Clara 1
Totale 567
Nome #
Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer 123
Bevacizumab in ovarian cancer: state of the art and unanswered questions 95
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients 85
null 72
Screening program in ovarian cancer: a logical step in clinical management? A meta-analysis 67
An unexpected complete remission of advanced intestinal-type vulvar adenocarcinoma after neoadjuvant chemotherapy: a case report and a literature review. 66
Dualistic classification of epithelial ovarian cancer: Surgical and survival outcomes in a large retrospective series 64
null 58
null 48
Post-conization cervical stenosis treated with silicone catheter in microinvasive cervical cancer patient: a case report 46
null 32
Short-Infusion Trabectedin in Heavily Pretreated Ovarian Cancer Patients: A Single-Institution Experience 14
Trabectedin in heavily pretreated recurrent ovarian cancer patients: a case-control study 12
Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study 11
Secondary Cytoreduction in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Institution Experience 9
Totale 802
Categoria #
all - tutte 1.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020208 0 0 7 11 21 26 33 39 29 27 12 3
2020/202164 5 16 5 4 1 6 0 6 10 6 4 1
2021/202291 0 8 9 2 12 5 2 12 6 4 11 20
2022/2023112 21 25 7 19 8 8 6 2 6 0 5 5
2023/202471 5 8 3 9 6 8 3 11 1 7 6 4
2024/202516 2 13 1 0 0 0 0 0 0 0 0 0
Totale 802